Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies
The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.
Abstract
Adherence to osteoporosis medications is relatively poor. Approximately 20-30% of patients taking daily or weekly treatments may suspend their treatment within 6 to 12 months of initiating therapy. Patients with poor adherence increase their risk of osteoporotic fractures and hospitalisation. The majority of patients who discontinue therapy appear to do so because of drug-induced adverse effects. Fear of adverse effects or other health risks is another commonly cited reason for discontinuing therapy. Factors associated with medication adherence include fractures, regular exercise, female sex, fewer non-osteoporosis medications and co-morbidities, early menopause, willingness to take medications, awareness of osteoporosis status based on a diagnostic test, anti-inflammatory therapy and corticosteroid therapy. Factors associated with non-adherence include adverse effects, pain and being unsure about bone mineral density (BMD) test results. Bisphosphonates, a common class of drugs for treating osteoporosis, have specific administration requirements (e.g. fasting, remaining upright and not ingesting other medications concomitantly). Patient surveys indicate that 12-18% of patients report non-compliance with at least one administration rule. Strategies to increase adherence include reducing administration frequency to weekly or monthly, monitoring patients with bone markers and BMD testing, providing adequate instructions, practitioner feedback and support, and educational materials and sessions. Future studies are needed regarding strategies to increase adherence to osteoporosis medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Poor adherence to anti-osteoporosis medication appears to be explained, at least in part, by a lack of awareness that osteoporosis is a major risk factor for fracture [6], and beliefs that osteoporosis is not a serious health condition and/or that the risks of anti-osteoporosis medications outweigh their benefits [7, 8].”
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Dawson-Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371003 · Cited by 2,277
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Research works printed but not linked: 5
- Haynes, 2005, Cochrane Database Syst Rev, 4, CD000011
- Segal, 2003, Isr Med Assoc J, 5, 859
- Lombas, 2001, J Bone Miner Res, 15, S529
- Pilon, 2001, Obstet Gynecol, 97, 97
- Morgan, 2004, Can J Clin Pharmacol, 11, e267
Cited by
Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis
Kothawala, P., Badamgarav, E., Ryu, S., Miller, R. M., & Halbert, R. J. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61093-8 · Cited by 307
Implantable biosensors and their contribution to the future of precision medicine
Gray, M., Meehan, J., Ward, C., Langdon, S. P., Kunkler, I. H., Murray, A., & Argyle, D. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.07.011 · Cited by 169
Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip Fracture
Jennings, L. A., Auerbach, A. D., Maselli, J. H., Pekow, P. S., Lindenauer, P. K., & Lee, S. J. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02769.x · Cited by 168
Adherencia y persistencia terapéutica: causas, consecuencias y estrategias de mejora
Dilla, T., Valladares, A., Lizán, L., & Sacristán, J. A. (2009) · Atención Primaria · doi:10.1016/j.aprim.2008.09.031 · Cited by 352
Mok, S.-K., Chen, W., Lai, W., Leung, P., Wang, X., Yao, X., & Wong, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00593.x · Cited by 158
Metadata
- Authors
- Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., & Adachi, J. D.
- Affiliations
- McMaster University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Venue
- Drugs & Aging
- Published
- 2007
- Volume
- 24
- Issue
- 1
- Pages
- 37-55
- ISSN
- 1170-229X (ISSN-L)
- OpenAlex
- W2043018151
- Cited by
- 151
- References
- 90
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 16 · 2012: 13
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- osteoporosis, medication adherence, treatment discontinuation, bisphosphonates, osteoporotic fractures, adverse drug reactions, bone densitometry, patient education, comorbidities, menopause, corticosteroid therapy, anti-inflammatory therapy
- MeSH terms
- Aged, Calcium, Diphosphonates, Drug Therapy, Combination, Female, Humans, Male, Osteoporosis, Patient Compliance, Vitamin D, Micronutrients, Hormone Replacement Therapy, Raloxifene Hydrochloride, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies. https://app.cochat.ai/papers/10.2165/00002512-200724010-00003
- The paper
- Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., & Adachi, J. D. (2007). Patient Adherence to Osteoporosis Medications: Problems, Consequences and Management Strategies. Drugs & Aging. https://doi.org/10.2165/00002512-200724010-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.